A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer

Stage III non-small cell lung cancer (NSCLC) comprises a highly heterogenous group of patients with regards to patient fitness and tumour size and distribution, resulting in a wide range of treatment goals and therapy options. Curative-intent multimodality treatment should be considered in all patie...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Anthony Brade, Kevin Jao, Simon Yu, Parneet Cheema, Sarah Doucette, Anna Christofides, Devin Schellenberg
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-04-01
Colecção:	Current Oncology
Assuntos:	stage III non-small cell lung cancer inoperable curative-intent chemoradiation therapy immunotherapy care pathway
Acesso em linha:	https://www.mdpi.com/1718-7729/28/3/151
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!